Gilead Sciences Inc (NASDAQ: GILD)
DRUGS - Biotechnology
Health Care
Stock price data as of
Closing price: $151.00
-
Support level$135.14
-
Resistance levelN/A
-
Beta0.4
-
RSI (14-day)70.7
- GILD is one of this month's top performers with a return of 13.4 percent, beating 90 percent of stocks in the S&P-100.
- Up 3.7 percent, GILD is one of this week's biggest gainers.
- Volatility is forecast to fall over the next month.
- GILD is above its 200-day moving average, providing a measure of support for long positions.
- With RSI > 70, GILD is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $110.56 | $155.80 | 90.9% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $134.36 | $136.60 | $144.35 | $148.62 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week7.4%
-
In the next month14.9%
-
In the next year52.8%
| Period | Value |
|---|---|
| Historical (5 year) | 24.4% |
| Last month | 26.0% |
| Current estimate | 27.3% |
| Next month forecast | 26.4% |